Predicting Drug Interaction Potential With a Physiologically Based Pharmacokinetic Model: A Case Study of Telithromycin, a Time-Dependent CYP3A Inhibitor-Reference-Cited by-同舟云学术

Predicting Drug Interaction Potential With a Physiologically Based Pharmacokinetic Model: A Case Study of Telithromycin, a Time-Dependent CYP3A Inhibitor

Published:2012-03-07 Issue:4 Volume:91 Page:700-708
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Vieira Md L T,Zhao P,Berglund E G,Reynolds K S,Zhang L,Lesko L J,Huang S-M

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference37 articles.

1. Clinical Pharmacokinetics of Telithromycin, the First Ketolide Antibacterial

2. Predicting Drug–Drug Interactions: An FDA Perspective

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative prediction of CYP3A induction-mediated drug-drug interactions in clinical practice;Drug Metabolism and Pharmacokinetics;2024-08

2. Practical Application of Pk/TK Models: Preclinical PK/TK and Clinical Trial;Handbook of Pharmacokinetics and Toxicokinetics;2023-07-03

3. Drug-drug interactions involving CFTR modulators: a review of the evidence and clinical implications;Expert Opinion on Drug Metabolism & Toxicology;2023-04-03

4. On the Verge of Impossibility: Accounting for Variability Arising from Permutations of Comorbidities that Affect the Fate of Drugs in the Human Body;AAPS Introductions in the Pharmaceutical Sciences;2023

5. Physiological‐based pharmacokinetic modeling trends in pharmaceutical drug development over the last 20‐years; in‐depth analysis of applications, organizations, and platforms;Biopharmaceutics & Drug Disposition;2021-01-17